Rhophylac (CSL Behring AG)
Welcome to the PulseAid listing for the Rhophylac drug offered from CSL Behring AG. This Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Endogenous Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: | CSL Behring AG |
NON-PROPRIETARY NAME: | HUMAN RHO(D) IMMUNE GLOBULIN |
SUBSTANCE NAME: | HUMAN RHO(D) IMMUNE GLOBULIN |
TYPE: | PLASMA DERIVATIVE |
PHARMA CLASS: | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Endogenous Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2009-01-06 |
END MARKETING DATE: | 0000-00-00 |
Rhophylac PLASMA DERIVATIVE Details:
Item Description | Rhophylac from CSL Behring AG |
LABELER NAME: | CSL Behring AG |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1500([iU]/2mL) |
START MARKETING DATE: | 2009-01-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 44206-300_81aef654-4f74-4547-a259-d558b6869c54 |
PRODUCT NDC: | 44206-300 |
APPLICATION NUMBER: | BLA125070 |
Other HUMAN RHO(D) IMMUNE GLOBULIN Pharmaceutical Manufacturers / Labelers: